Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Clinical trial NCT05124002 · UNKNOWN
Trial details
- NCT number
- NCT05124002
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2026-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.